Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial
- Resource Type
- Source
- Hepatology International.
- Subject
Hepatology - Language
- ISSN
- 1936-0541
1936-0533